You are here: Industry Insights > Roche

News List

The top 10 medtech companies of 2024 fiercebiotech
January 03, 2019
While most of the world’s top 10 medtech companies are expected to defend their relative rankings in the coming years, ambitious or inspired M&A deals could give companies lower on the list the oomph to move up and ......
Roche taps Icagen in neuro drug discovery deal worth up to $274M fiercebiotech
January 02, 2019
Roche and Icagen have inked a licensing and collaboration deal around ion channel modulators for neurological disorders. The duo did not disclose Roche’s upfront payment or research funding......
Roche to develop new dMMR pan-cancer test for Merck’s Keytruda immunotherapy fiercebiotech
December 26, 2018
If you can’t beat 'em, join 'em: Roche is teaming up with its immuno-oncology competitor Merck & Co. to develop a pan-cancer companion diagnostic test for its Keytruda therapy aimed at
Roche claims US approval for novel flu treatment pharmaphorum
December 20, 2018
The US FDA has given a green light to a new influenza treatment from Shionogi and Roche that has the first new mechanism of action in more than two decades......
Roche gets PRIME designation for SMA drug in Europe pharmaceutical-technology
December 20, 2018
Roche has secured PRIME designation from the European Medicines Agency (EMA) for its risdiplam (RG7916) medicine to treat spinal muscular atrophy (SMA).
Roche’s SMA drug gets PRIME regulatory status in Europe pharmaphorum
December 19, 2018
Roche is hoping to challenge Biogen with a new treatment for the rare muscle wasting disease spinal muscular atrophy – and the plans just got a boost after European regulators gave it special priority.
FDA agrees to review Roche’s Tecentriq combination for breast cancer pharmaceutical-technology
December 18, 2018
The US Food and Drug Administration (FDA) has accorded priority review status to the supplemental biologics licence application (sBLA) of Roche’s Tecentriq (atezolizumab) as a combination therapy for breast cancer......
AbbVie, Roche eye first-line use of Venclexta in leukaemia pharmaphorum
December 17, 2018
AbbVie and Roche’s Venclexta has hit the mark in a combination trial that could help it move into the treatment-naive chronic lymphocytic leukaemia (CLL) arena......
Gilead appoints current Roche Pharmaceuticals CEO as new CEO and chairman pharmaceutical-technology
December 11, 2018
The board of directors at Gilead Sciences has announced it has chosen Daniel O’Day, the current CEO of Roche Pharmaceuticals and member of the Roche Group’s corporate executive committee.....
Roche’s lung cancer combo treatment wins FDA approval expressbpd
December 11, 2018
The approval was based on results from a late-stage study, which showed the Tecentriq regimen helped patients with metastatic non-squamous non-small cell lung cancer (NSCLC)

Previous page 1 2 3 4 5 6 7 8 9 10 ... 45 46 Next page